SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is experiencing intense volatility as traders react to conflicting signals involving renewed strikes in the Middle East and ongoing speculation regarding potential diplomatic breakthroughs. Community sentiment remains deeply divided between those betting on further supply shocks and higher prices due to geopolitical escalations, and those anticipating aggressive market interventions or potential ceasefires.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors react to Temasek's recent stake disclosure and broader anticipation of a rebound heading into the next earnings report. The community is actively debating the company's long-term growth potential and store expansion against persistent concerns regarding its OTC status and historical volatility.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is experiencing renewed investor interest and technical strength, with shares pushing toward a key resistance level as sentiment shifts following the EU approval of its oral Wegovy pill. The community is actively debating the stock's long-term valuation relative to Eli Lilly and discussing the potential for a sustained breakout as the company expands its global reach and pipeline visibility.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending heavily as investors speculate on a major anchor tenant deal, with community discussion centered on a significant executive performance incentive that creates a clear deadline for a contract announcement. While the stock has seen high volatility due to a recent convertible note offering, many participants are actively accumulating shares, viewing the current price action as a strategic opportunity before the potential for a major catalyst.

Ambarella, Inc. engages in the development of low-power system-on-a-chip (SoC), semiconductors, and software for edge artificial intelligence (AI) applications and intelligent automation. The firm's products include video security, advanced driver assistance (ADAS), electronic mirror, drive recorder, driver or cabin monitoring, autonomous driving, and other robotics applications. It operates through the following geographical segments: Taiwan, Asia Pacific, Europe, North America, and United States. The company was founded by Feng Ming Wang and Leslie D. Kohn on January 15, 2004 and is headquartered in Santa Clara, CA.

Ambarella Inc

Ambarella shares are surging as investors react to reports of potential acquisition interest from NXP Semiconductors, a move seen as a strategic play to bolster NXP's presence in edge AI and automotive vision technology. While the community is debating the potential takeover premium, some traders are expressing skepticism regarding the deal's viability, keeping a close watch on potential counter-bidders and overall volatility.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpool is facing significant market pressure ahead of earnings as investors debate whether the company is a deep-value turnaround play or a structural value trap hampered by heavy debt and weakening consumer demand. Community discussion is sharply divided between those calling for a board shakeup due to persistent underperformance and contrarian investors who are accumulating shares, citing the company's iconic status and historical oversold conditions.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors react to the company's aggressive repurchase of its convertible senior notes, signaling internal confidence ahead of anticipated commercial catalysts. The community is actively debating the timing of the YARTEMLEA J-code activation, upcoming CMS NTAP approval, and the potential for a near-term milestone payment from their Novo Nordisk partnership.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is trending due to heightened speculation surrounding a potential acquisition by Johnson & Johnson, fueled by recent corporate restructuring that simplifies the company's organizational framework. Community discussions are centered on the significant commercial momentum of the blockbuster therapy Carvykti, alongside intense debate over the strategic departure of key leadership and the long-term potential of the firm's in vivo CAR-T pipeline.

Jersey Mike's Subs, Inc. engages in franchising fast casual, submarine-style sandwich restaurants specializing in authentic, hand-crafted, and craveable subs. The company was founded by Peter Cancro in 1956 and is headquartered in Tinton Falls, DE.

Jersey Mike`s Subs Inc. - Ordinary Shares - Class A

Jersey Mike's Subs recently completed its high-profile public debut on the NYSE, sparking intense community debate as the stock opened below its initial offering price. Investors are actively split between those betting on the brand's rapid expansion potential and long-term growth and those expressing skepticism over its valuation, debt levels, and the sustainability of premium pricing in the current economic environment.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is currently trending as investors weigh strong fundamental performance against recent volatility triggered by cautious analyst commentary on e-commerce adoption. The community remains deeply divided, with many aggressively accumulating shares as a long-term AI-driven advertising play while others express frustration over sharp price swings and ongoing technical selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CYDY Have you ever, in all your investing, of any industry, heard a CEO say something could be --- 
 
A game changer. 
 
&amp; it not turn out to be true ?? 
 
3 of 3 times i have seen it be true. 
 
Cytodyn showing same characteristics. 
 
Ready for 4 of 4.

Zebra32

Robert

Lisa

LIVIMMUNE Bound

anh vo

Lou Monti

Clark Kent

Thomas H Butcher

Mark Hayden

Pro Cytodyn

vivamiga

Scott

Ant Car

Jerry

StockTwits Web

CytoDyn Inc

 Have you ever, in all your investing, of any industry, heard a CEO say something could be --- 
 
A game changer. 
 
& it not turn out to be true ?? 
 
3 of 3 times i have seen it be true. 
 
Cytodyn showing same characteristics. 
 
Ready for 4 of 4.